Azopt and Telmisartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azopt (brinzolamide) and Telmisartan (telmisartan). Common drug interactions include toxic epidermal necrolysis among females.

The phase IV clinical study analyzes what interactions people have when they take Azopt and Telmisartan. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Azopt?

Azopt has active ingredients of brinzolamide. It is often used in glaucoma. eHealthMe is studying from 8,058 Azopt users. Check the latest studies of Azopt.

What is Telmisartan?

Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.

On Jul, 15, 2026

73 people who take Azopt and Telmisartan together, and have interactions are studied.

Azopt and Telmisartan drug interactions.

What are the common drug interactions of Azopt and Telmisartan, by gender? *:

female:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Haemoglobin decreased
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Ovarian neoplasm (tumour of ovary)
Pain
Plasma cell myeloma (cancer that begins in plasma cells)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Uterine cancer
Rash erythematous (redness of the skin)

male:

n/a

What are the common drug interactions of Azopt and Telmisartan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Renal cyst ruptured (tear of renal cyst)
Ovarian neoplasm (tumour of ovary)
Uterine cancer

50-59:

Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Plasma cell myeloma (cancer that begins in plasma cells)

60+:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Haemoglobin decreased
Rash erythematous (redness of the skin)
Rash papular (redness with papule)
Nikolsky's sign
Epidermal necrosis (skin condition that is usually caused by a reaction to drugs)
Eye discharge
Eye irritation
Foreign body sensation in eyes (feeling of something in eye)

What are the existing conditions these people have? *

Joint Pain: 62 people, 84.93%
Sinusitis (inflammation of sinus): 59 people, 80.82%
Menopausal Symptoms: 42 people, 57.53%
Insomnia (sleeplessness): 42 people, 57.53%
Dyslipidaemia (abnormal amount of lipids): 40 people, 54.79%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 36 people, 49.32%

* Approximation only. Some reports may have incomplete information.

Do you take Azopt and Telmisartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously